Keystone Symposia

Keystone Symposia Scientific Advisory Board


The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.

To learn more about the functions of the SAB, please click here.

Board of Directors are denoted with a # following their name.


E. Dale Abel, M.D., Ph.D.#
Director F.O.E. Diabetes Research Center
Professor of Medicine and Biochemistry
University of Iowa, Carver College of Medicine

Clement Adebamowo, B.M., Ch.B., Hons, Sc.D.
Professor Epidemiology and Public Health
Associate Director Population Science,
Greenebaum Comprehensive Cancer Center
Member, Institute of Human Virology
University of Maryland School of Medicine

Karen Adelman, Ph.D.
Professor
Biological Chemistry and Molecular Pharmacology
Harvard Medical School

Luciano Adorini, M.D.
Chief Scientific Officer
Preclinical Research
Intercept Pharmaceuticals, Inc.

Muhammad Al-Hajj, Ph.D.
Senior Vice President Translational Medicine
Translational Sciences
Autolus Therapeutics

Zoltan P. Arany, M.D., Ph.D.
Professor
Medicine
University of Pennsylvania

Eric H. Baehrecke, Ph.D.
Professor
Molecular, Cell and Cancer Biology
University of Massachusetts Medical School

Yasmine Belkaid, Ph.D.
Director NIAID Microbiome Program
Chief Mucosal Immunology Section
Laboratory of Parasitic Disease
NIAID, National Institutes of Health

Ralph A. Bradshaw, Ph.D.#
Professor Emeritus
Department of Physiology and Biophysics
University of California, Irvine

Cherié L. Butts, Ph.D.#
Medical Director
Digital & Quantitative Medicine
Biogen Inc

Robert Califf, M.D., MACC#
Head of Medical Strategy and Policy for Verily and Google Health
Verily Life Sciences, Google Health

Ian M. Colrain, Ph.D.#
President SRI International
SRI Biosciences

Roger D. Cone, Ph.D.
Director
Life Sciences Institute
University of Michigan

Feng Cong, Ph.D.
Director
Chemical Biology & Therapeutics
Novartis Institutes for BioMedical Research

John E. Connolly, Ph.D.
Chief Scientific Officer, Parker Institute for Cancer Immunotherapy
Senior Principal Investigator and Director for Translational Immunology, Institute of Molecular and Cell Biology

Rodrigo Corrêa-Oliveira, Ph.D.
Vice President
Research and Biological Collections
FIOCRUZ

Ana Maria Cuervo, M.D., Ph.D.
Professor, Department of Developmental and Molecular Biology
Co-Director, Institute for Aging Studies
Albert Einstein College of Medicine

Robertus de Bruin, Ph.D.
Professor, Molecular Cancer Biology
MRC Laboratory for Molecular Cell Biology
University College London

Robert J. Deans, Ph.D.
Chief Scientific Officer
Synthego Corporation

Russell A. DeBose-Boyd, Ph.D.
Professor
Molecular Genetics
University of Texas Southwestern Medical Center

Edward A. Dennis, Ph.D.#
Chancellor Distinguished Professor
Chemistry, Biochemistry and Pharmacology
School of Medicine
University of California, San Diego

Suzanne Devkota, Ph.D.
Assistant Professor
Karsh Division of Gastroenterology
Cedars-Sinai Medical Center

Vishva M. Dixit, M.D.#
Vice President, Early Discovery Research and Physiological Chemistry
Genentech, Inc.

Aris N. Economides, Ph.D.
Vice President
Research
Regeneron Pharmaceuticals, Inc.

Kelly A. Frazer, Ph.D.
Professor, Pediatrics
Director, Institute for Genomic Medicine
University of California San Diego School of Medicine

Mattias Fyrenius#
Publishing Director
Bonnier Carlsen

Stephan Gasser, Ph.D.
Senior Principal Scientist
CIT-4
Roche Innovation Center Zurich

Paloma Giangrande, Ph.D.
Director, Rare Disease, Moderna
Associate Professor, Internal Medicine
University of Iowa

Geoffrey S. Ginsburg, M.D., Ph.D.#
Director
The Duke Center for Applied Genomics & Precision Medicine
Duke University

Margaret A. Goodell, Ph.D.#
Professor and Chair
Department of Molecular and Cellular Biology
Director of Stem Cells & Regenerative Medicine Center
Vivian L. Smith Chair of Regenerative Medicine
Baylor College of Medicine

Curtis C. Harris, M.D.#
Chief, Laboratory of Human Carcinogenesis
NCI / National Institutes of Health

Tim Harris, Ph.D.
Venture Partner
SV Health Investors

Lora K. Heisler, Ph.D.
Chair in Human Nutrition
Obesity and Food Choice
Rowett Institute, University of Aberdeen

De' Broski R. Herbert, Ph.D.#
Associate Professor of Immunology
Department of Pathobiology
University of Pennyslvania

Linda Slanec Higgins, Ph.D.
Senior Vice President , Biology
Gilead Sciences, Inc.

Sean Hill, Ph.D.
Director, Krembil Centre for Neuroinformatics
Centre for Addiction and Mental Health
Professor, Department of Psychiatry, University of Toronto
Professor, Blue Brain Project, École Polytechnique Fédérale de Lausanne (EPFL)

Robert J. Hofmeister, Ph.D.
Chief Scientific Officer
TCR2 Therapeutics

Pamela M. Holland, Ph.D.
Vice President
Cancer Biology
Surface Oncology

Michael J. Holtzman, M.D.
Selman and Herman Seldin Professor, Medicine
Director, Pulmonary and Critical Care Medicine
Professor, Cell Biology and Physiology
Washington University in St. Louis

Tony Hunter, Ph.D.#
Professor and Principal Investigator
Molecular Cellular Biology Laboratories
The Salk Institute for Biological Sciences

Aron B. Jaffe, Ph.D.
Entrepreneur-in-Residence
Third Rock Ventures

Thale C. Jarvis, Ph.D.#
Chief Scientific Officer
Keystone Symposia

Sally John, Ph.D.
Vice President, Translational Biology
Research and Early Development
Biogen

Deborah L. Johnson, Ph.D.#
President and Chief Executive Officer
Keystone Symposia on Molecular and Cellular Biology

Takashi Kadowaki, M.D., Ph.D.
Professor and Chairman
Graduate School of Medicine, Diabetes and Metabolic Diseases
University of Tokyo

Véronique Kiermer, Ph.D.#
Executive Editor and Publisher
Publishing and Editorial
Public Library of Science (PLOS)

Karla A. Kirkegaard, Ph.D.
Violetta Horton Professor
Genetics & Microbiology & Immunology
Stanford University School of Medicine

Melanie A. Kleinschek, D.V.M., Ph.D.
Chief Scientific Officer
TRex Bio

Mark Kowala, B.Sc., Ph.D.
Chief Scientific Officer
Cardiometabolic
Eli Lilly Research Lab

Martin Kussmann, Ph.D.
Senior Scientist
Vydiant

Jeffery L. Kutok, M.D., Ph.D.
Chief Scientific Officer
Epizyme, Inc.

Tony K.T. Lam, Ph.D.
Professor and J.K. McIvor Endowed Chair in Diabetes Research
Canada Research Chair in Obesity
Associate Director, Banting and Best Diabetes Centre
Advanced Diagnostics and Metabolism
Toronto General Research Institute

Dangsheng Li, Ph.D.
Deputy Editor-in-Chief
Cell Research
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

Jean K. Lim, Ph.D.
Associate Professor
Microbiology
Icahn School of Medicine at Mount Sinai

Sarah Lively, Ph.D.
Vice President, Innovation and New Technologies
Head, San Francisco Site
ChemPartner Corporation

Juan Carlos Lopez, Ph.D.#
Founder
Haystack Science

Patrick Mayes, Ph.D.
Executive Director
Immuno-Oncology Antibodies
Incyte Research Institute

M. Juliana McElrath, M.D., Ph.D.
Senior Vice President, Director and Member
Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center

Valerie Mizrahi, Ph.D.
Director
Institute of Infectious Disease and Molecular Medicine (IDM)
University of Cape Town

Craig Monell, Ph.D.
Vice President
Business Operations/R&D
BioLegend, Inc.

Walter H. Moos, Ph.D.#
Managing Director, Pandect Bioventures
CEO, ShangPharma Innovation
Professor (adj.), University of California, San Francisco
President (ret.), SRI Biosciences

Richard A. Morgan, Ph.D.
Senior Vice President
Immunogenetics
Editas Medicine

Lily Y. Moy, Ph.D.
Director, Pharmacology
Quantitative Biosciences
Merck & Co.

Dominik Mumberg, Ph.D.
Vice President
Oncology II
Bayer AG

Leon O. Murphy, Ph.D.
Chief Scientific Officer
Casma Therapeutics

Lee A. Niswander, Ph.D.
Professor and Chair
Molecular, Cellular and Developmental Biology
University of Colorado Boulder

Anne O'Garra, Ph.D., FRS, FMedSci#
Associate Research Director
The Francis Crick Institute
Mill Hill Laboratory

Wenjun Ouyang, Ph.D.
Executive Director
Inflammation and Oncology, Research
Amgen, Inc.

Deborah Palliser, Ph.D.
Immunology Strategy Lead
Rare Diseases Drug Discovery Unit
Takeda

Paul W. H. I. Parren, Ph.D.
Professor
Department of Immunohematology and Blood Transfusion
Leiden University Medical Center

Mark J. Powers, Ph.D.
Senior Director, Research and Development- Cell Biology
Thermo Fisher Scientific

Bali Pulendran, Ph.D.
Professor, Pathology and of Microbiology and Immunology
Stanford University School of Medicine

Michael H. Rabinowitz, Ph.D.
Vice President
Research
Akebia Therapeutics, Inc

Laszlo Radvanyi, Ph.D.
President and Scientific Director
Ontario Institute for Cancer Research

Sridhar Ramaswamy, M.D.
Entrepreneur in Residence
Google Ventures

Richard M. Ransohoff, M.D.
Venture Partner
Third Rock Ventures

Rino Rappuoli, Ph.D.
Chief Scientist and Head of External Research and Development
GlaxoSmithKline Vaccines

Bing Ren, Ph.D.
Professor
Ludwig Institute for Cancer Research

Christopher J. Rhodes, BSc, PhD
Chief Scientist, Cardiovascular, Renal & Metabolism, BioPharmaceuticals R&D, AstraZeneca
Professor, University of Chicago

Mark Rolfe, Ph.D.
Corporate Vice President
Research & Early Development
Celgene Corporation

Pamela C. Ronald, Ph.D.
Distinguished Professor
Plant Pathology and the Genome Center
University of California, Davis

Cristina M. Rondinone, Ph.D.
President
Cellarity Inc.

Deepak Sampath, Ph.D.
Vice President, Head of Research
Ultragenyx

Thomas J. Schuetz, M.D., Ph.D.
Co-Founder, Chief Executive Officer, Director
Compass Therapeutics

Janine Schuurman, Ph.D.
Corporate Vice President
Research and Innovation
Genmab

Ali Shilatifard, Ph.D.
Robert Francis Furchgott Professor
Chairman, Department of Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine

Barry P. Sleckman, M.D., Ph.D.
Director, O'Neal Comprehensive Cancer Center
University of Alabama Birmingham School of Medicine

Hans Ulrich Stilz, Ph.D.
Vice President
R&D Innovation and Outreach
Novo Nordisk A/S

Boris Striepen, Ph.D.
Professor of Microbiology and Immunology
Department of Pathobiology
School of Veterinary Medicine
University of Pennsylvania

Lynda M. Stuart, M.D., Ph.D.
Deputy Director
Global Health, Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Lori Sussel, Ph.D.#
Professor and Director of Research
Basic and Translational Research Division, Barbara Davis Center
University of Colorado Anschutz Medical Campus

Paul K.H. Tam, ChM
Li Shu-Pui Professor and Chair of Pediatric Surgery
Department of Surgery
Director, Dr. Li Dak Sum Research Centre
The University of Hong Kong-Karolinska Institutet Collaboration in Regenerative Medicine

Cormac Taylor, Ph.D.
Professor, Cellular Physiology
Medicine
University College Dublin

Kathrin Tissot, M.D., Ph.D.
Business Team Head
MorphoSys AG

Cornelia Liu Trimble, M.D.
Professor
Gynecology and Obstetrics, Oncology, and Pathology
Johns Hopkins University School of Medicine

Fred Van Goor, Ph.D.
Principal Research Fellow
Research
Vertex Pharmaceuticals Incorporated

Yibin Wang, Ph.D.
Professor
Anesthesiology, Physiology and Medicine
University of California, Los Angeles
David Geffen School of Medicine

Andrew B. Ward, Ph.D.
Professor
Integrative Structural and Computational Biology
The Scripps Research Institute

Stephanie Wengert Watts, Ph.D.
Professor, Assistant Dean
Pharmacology & Toxicology
Michigan State University

Charles E. Whitehurst, Ph.D.
Senior Associate Director
Immunology and Respiratory
Boehringer Ingelheim Pharmaceuticals, Inc.

Joseph C. Wu, M.D., Ph.D.
Professor and Director of Stanford Cardiovascular Institute
Medicine and Radiology
Stanford University School of Medicine

Xuebiao Yao, Ph.D.
Professor and Head
Cellular Dynamics
University of Science & Technology of China

Jonathan Zalevsky, Ph.D.
Chief Research & Development Officer
Biology
Nektar Therapeutics

Bei B. Zhang, Ph.D.#
Vice President, Metabolic Research
Worldwide Research and Development
Internal Medicine
Pfizer Inc.

Juleen R. Zierath, Ph.D.#
Professor
Department of Molecular Medicine and Surgery
Karolinska Institutet

Arturo Zychlinsky, Ph.D.
Director
Cellular Microbiology
Max Planck Institute for Infection Biology

plus representatives to be announced from:
AbbVie Inc.
AstraZeneca
BlueRock Therapeutics
Bristol-Myers Squibb Company
Ionis Pharmaceuticals, Inc.
Pfizer Inc.
Sanofi US